✦ LIBER ✦

Anticholinergics for parkinson disease

✍ Scribed by Howard I. Hurtig

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 122 KB
Volume: 7
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410070525

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dementia in Parkinson disease

✍ Dr Abraham Lieberman; Marie Dziatolowski; Mark Kupersmith; Michael Serby; Albert 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views

Alcohol and Parkinson disease

✍ A. E. Lang; Prof C. D. Marsden; J. A. Obeso; J. D. Parkes 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Alcohol and Parkinson disease

✍ William C. Koller 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

Dorsal subthalamotomy for Parkinson's di

Dorsal subthalamotomy for Parkinson's disease

✍ L. Alvarez; R. Macias; J. Guridi; G. Lopez; E. Alvarez; C. Maragoto; J. Teijeiro 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

Criteria for diagnosing Parkinson's dise

Criteria for diagnosing Parkinson's disease

✍ Dr. D. B. Calne; B. J. Snow; C. Lee 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Therapies for dopaminergic-induced dyski

Therapies for dopaminergic-induced dyskinesias in parkinson disease

✍ Mildred D. Gottwald; Michael J. Aminoff 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 2 views

## Abstract Existing and emerging strategies for managing L‐dopa–induced dyskinesias (LIDs) in patients with Parkinson disease have involved either delaying the introduction of L‐dopa therapy, treatment with an antidyskinetic agent, using a therapy or delivery system that can provide continuous dop